Insider trades
Gary K. Lee, Chief Officer of Lyell Immunopharma LYEL, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $47.2K. The latest trade was on 05/11.
Gary K. Lee
Chief Scientific Officer
- Company
- Lyell Immunopharma LYEL
- First filing
- 23/02/28
- Trades
- 19 trades
- Buys / sales
- 0 / 7
- 12-month net buying
- −$47.2K
- Last trade
- 05/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 05/11 | 06/15 | 130 sh | $18.92 | $2,459.6 | −0.7% | |
| Open-market sale | 02/11 | 02/12 | 1,671 sh | $23.39 | $39,084.69 | −9.0% | |
| Open-market sale | 02/10 | 02/11 | 147 sh | $23.12 | $3,398.64 | −0.8% | |
| Open-market sale | 25/11/10 | 25/11/12 | 138 sh | $16.16 | $2,230.08 | −0.9% | |
| Open-market sale | 25/08/21 | 25/08/22 | 1,453 sh | $10.54 | $15,314.62 | −8.6% | |
LYEL | Open-market sale | 25/08/11–25/08/12 | 25/08/13 | 267 sh2 trades | $10.43avg. | $2,785.67 | −2.9% |